MetaCap

Fortrea (FTRE) vs Trupanion (TRUP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Fortrea (FTRE) has outperformed Trupanion (TRUP) over the past year, gaining 70.2% versus a loss of 0.9%. Fortrea is the larger company by market cap ($1.79 billion vs $1.54 billion), about 1.2 times the size, while Trupanion is growing revenue faster (+11.9% vs +1.0%). On valuation, Trupanion trades at a lower forward P/E (8.1x vs 16.5x for Fortrea).

Trupanion converts more of its revenue into profit, with a net margin of 1.4% versus -36.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FTRE+70.18%TRUP-0.95%
+146%+49%-49%
Nov 21, 20251 yearNov 20, 2026
FTRE-38.37%TRUP+36.32%
+125%+14%-97%
Jun 12, 20235 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FTRE versus TRUP key metrics
MetricFTRETRUP
Share price$18.55$35.56
Market cap$1.79B$1.54B
1-day change-7.94%-0.86%
YTD return+7.54%-4.84%
1-year return+70.18%-0.95%
5-year return—-71.95%
P/E ratio (TTM)—58.30
Forward P/E16.528.14
EPS (TTM)$-0.73$0.61
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.72B$1.44B
Revenue growth (YoY)+1.00%+11.95%
Net income (latest FY)$-986.20M$19.43M
Gross margin18.50%16.05%
Operating margin-32.04%0.96%
Net margin-36.21%1.35%
52-week high$26.16$38.87
52-week low$8.55$21.16
Distance from 52-week high-29.09%-8.52%
Analyst consensusbuybuy
Avg. price target upside+27.39%+3.35%
Average volume1.69M443.82K
Shares outstanding96.50M43.26M
Employees14,0001,121
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FTRE has outperformed TRUP by 71.1 percentage points over the past year.
  • Trupanion is more profitable, keeping 1.4 cents of every revenue dollar as net income versus -36.2 cents for Fortrea.
  • Trupanion grew revenue faster in its latest fiscal year (+11.95% vs +1.00%).

About Fortrea

FTRE stock →

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.

Health Care · Medical Specialities · 14,000 employees

About Trupanion

TRUP stock →

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business.

Health Care · Medical Specialities · 1,121 employees

FTRE vs TRUP FAQ

Which is bigger, Fortrea or Trupanion?

Fortrea (FTRE) is larger, with a market capitalization of $1.79B compared with $1.54B for Trupanion (TRUP).

Which stock has performed better over the past year, FTRE or TRUP?

FTRE returned +70.18% over the past 12 months, compared with -0.95% for TRUP (price return, excluding dividends). Past performance does not predict future results.

Are Fortrea and Trupanion in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons